How Integrating Costs into Your Evaluation Generates Funding Opportunity: The Case of Naloxone

In public health evaluation, it is common to translate program outcomes into cost-effectiveness metrics. The goal is not to place a value on human life, but rather to illustrate how relatively modest investments in prevention can generate substantial, life-saving impact.

Consider a naloxone distribution program.

Imagine a program distributes 10,000 naloxone kits in a year. To make the math simple, assume each kit costs $50. That means the direct supply cost is: